News about Drug Discovery & Development

India Begins First Human Trials of Indigenous KFD Vaccine

The Indian Council of Medical Research (ICMR), in partnership with Indian Immunologicals, has advanced an indigenous vaccine candidate for Kyasanur Forest Disease (KFD), commonly known as monkey fever, into Phase I human clinical trials.

Drug Discovery & Development | 09/02/2026 | By Darshana |  241

FDA Grants Orphan Drug Designation to Zenocutuzumab for Rare Cholangiocarcinoma Subset

Partner Therapeutics secures Orphan Drug Designation for zenocutuzumab-zbco in NRG1 fusion-positive cholangiocarcinoma, strengthening development of targeted therapy for this aggressive rare cancer.

Drug Discovery & Development | 09/02/2026 | By News Bureau |  175

Evogene's Biomica Signs Global Licensing Deal with Lishan Biotech for Microbiome-Based Cancer Therapy BMC128

Lishan Biotech secures exclusive worldwide rights to develop and commercialise BMC128, a Phase I microbiome-based immunotherapy candidate showing early promise in lung and renal cancers.

Drug Discovery & Development | 07/02/2026 | By News Bureau |  128

Sun Pharma to Invest Rs 500 Crore in Expansion of Assam Manufacturing Unit

Sun Pharmaceutical Industries said it will invest Rs 500 crore to expand its manufacturing facility in Assam, aiming to strengthen its domestic production infrastructure and support future growth.

Drug Discovery & Development | 06/02/2026 | By Darshana |  211

Lupin Launches Dasatinib Tablets in USA Following FDA Approval

Lupin Limited has announced the launch of dasatinib tablets in multiple strengths in the United States following approval of its Abbreviated New Drug Application from the USA Food and Drug Administration.

Drug Discovery & Development | 03/02/2026 | By Darshana |  259

Frontage Labs Expands Early-Phase Clinical Capabilities for Global Drug Development

Frontage's US operations are anchored by a modern 160?bed, 36,000?sq?ft phase-I clinical unit in Secaucus, New Jersey, designed to conduct large?scale phase-I and bioequivalence (BE) studies as well as radiolabeled human AME research.

Drug Discovery & Development | 31/01/2026 | By News Bureau |  121

NanoMosaic Secures FDA AMT Designation for Nanoneedle Technology in AAV Gene Therapy Manufacturing

FDA’s CBER grants Advanced Manufacturing Technology designation to NanoMosaic’s Nanoneedle platform, enhancing regulatory engagement and streamlining quality control in AAV gene therapy production.

Drug Discovery & Development | 30/01/2026 | By News Bureau |  176

Grail Submits Final PMA Module to FDA for Galleri Multi-Cancer Early Detection Test

Grail files the final Premarket Approval module with the FDA for its Breakthrough Device-designated Galleri test, supported by data from over 25,000 participants in PATHFINDER 2 and the NHS-Galleri trial.

Drug Discovery & Development | 30/01/2026 | By News Bureau |  512

European Commission Expands Bracco's Vueway Approval to Infants and Neonates

Bracco Imaging secures EU approval to extend Vueway’s use to infants and neonates, enhancing safe and effective MRI diagnostics for young patients.

Drug Discovery & Development | 28/01/2026 | By News Bureau |  157

European Commission Expands GSK's RSV Vaccine Arexvy to Adults Aged 18 and Above

GSK’s RSV vaccine Arexvy receives European approval for adults aged 18 plus, marking a major expansion in protection against RSV-related respiratory illness across the region.

Drug Discovery & Development | 28/01/2026 | By News Bureau |  153